U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020386

Expand all

COZAAR (LOSARTAN POTASSIUM)
25MG
Marketing Status: Prescription
Active Ingredient: LOSARTAN POTASSIUM
Proprietary Name: COZAAR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020386
Product Number: 001
Approval Date: Apr 14, 1995
Applicant Holder Full Name: ORGANON LLC A SUB OF ORGANON AND CO
Marketing Status:  Prescription
Patent and Exclusivity Information
COZAAR (LOSARTAN POTASSIUM)
50MG
Marketing Status: Prescription
Active Ingredient: LOSARTAN POTASSIUM
Proprietary Name: COZAAR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N020386
Product Number: 002
Approval Date: Apr 14, 1995
Applicant Holder Full Name: ORGANON LLC A SUB OF ORGANON AND CO
Marketing Status:  Prescription
Patent and Exclusivity Information
COZAAR (LOSARTAN POTASSIUM)
100MG
Marketing Status: Prescription
Active Ingredient: LOSARTAN POTASSIUM
Proprietary Name: COZAAR
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N020386
Product Number: 003
Approval Date: Oct 13, 1998
Applicant Holder Full Name: ORGANON LLC A SUB OF ORGANON AND CO
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top